Vaxart (VXRT) Stock Chart & Stock Price History $0.36 -0.01 (-1.36%) As of 03:59 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vaxart Stock Price Performance The Vaxart (VXRT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 58.46%, with a year-to-date return of -45.25%. In the past month, the stock has decreased 17.61%, reflecting recent market activity. As of the latest close, Vaxart traded at $0.37 with a market cap of $83.47 million and volume of 419,463 shares. Five years ago, the stock traded at $8.81, representing a 95.89% decrease over that period. At the time, it had a market cap of $1.04 billion and a volume of 6.98 million shares. Receive VXRT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vaxart and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.96%1 Month Performance-17.61%3 Month Performance-28.64%Year-To-Date Performance-45.25%1 Year Performance-58.46%5 Year Performance-95.89% VXRT Stock Chart for Wednesday, August, 20, 2025 VXRT Chart by TradingView Vaxart Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/19/2025$0.36$0.37+0.80%$0.38$0.35419,463 shs$83.47 million08/18/2025$0.37$0.36-0.38%$0.38$0.35383,752 shs$83.47 million08/15/2025$0.36$0.37+1.67%$0.38$0.35714,231 shs$83.78 million08/14/2025$0.38$0.36-6.37%$0.38$0.36319,475 shs$82.41 million08/13/2025$0.39$0.38-0.65%$0.40$0.35729,995 shs$88.02 million08/12/2025$0.37$0.39+4.79%$0.40$0.35337,012 shs$88.59 million08/11/2025$0.38$0.37-2.82%$0.40$0.36430,054 shs$84.54 million08/08/2025$0.39$0.38-2.71%$0.40$0.38273,111 shs$86.99 million08/07/2025$0.40$0.39-2.35%$0.40$0.38393,111 shs$89.41 million08/06/2025$0.37$0.40+8.99%$0.42$0.341.30 million shs$91.57 million Get the Latest News and Ratings for VXRT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaxart and its competitors with MarketBeat's FREE daily newsletter. 08/05/2025$0.37$0.37-0.78%$0.37$0.34438,322 shs$84.01 million08/04/2025$0.36$0.37+3.96%$0.37$0.32325,711 shs$84.68 million08/01/2025$0.36$0.36-0.17%$0.40$0.33701,497 shs$81.45 million07/31/2025$0.37$0.36-2.36%$0.40$0.35863,088 shs$81.59 million07/30/2025$0.40$0.37-8.50%$0.40$0.37931,672 shs$83.55 million07/29/2025$0.41$0.40-1.51%$0.41$0.38701,594 shs$91.31 million07/28/2025$0.40$0.41+1.25%$0.44$0.391.04 million shs$92.71 million07/25/2025$0.41$0.40-1.96%$0.42$0.391.57 million shs$91.57 million07/24/2025$0.42$0.41-2.86%$0.44$0.40745,434 shs$93.40 million07/23/2025$0.41$0.42+3.70%$0.42$0.40710,925 shs$96.14 million07/22/2025$0.42$0.41-4.68%$0.43$0.41697,495 shs$97.27 million07/21/2025$0.44$0.42-3.43%$0.45$0.402.17 million shs$97.27 million Related Companies Benitec Biopharma Stock Chart Canopy Growth Stock Chart Candel Therapeutics Stock Chart Rocket Pharmaceuticals Stock Chart Aldeyra Therapeutics Stock Chart Larimar Therapeutics Stock Chart Bright Minds Biosciences Stock Chart Altimmune Stock Chart Design Therapeutics Stock Chart Ocugen Stock Chart Receive VXRT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vaxart and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VXRT) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored"I'm risking my reputation on this"A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That...Crypto 101 Media | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxart, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxart With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access